I leverage my background in chemistry and pharmaceuticals to help life sciences clients monetize their intellectual property assets.
+1 202 842 7865 tblinka@cooley.com
Tom Blinka is a partner focused on patent procurement and counseling relating to chemical technologies. Tom brings to his client engagements his experience as a researcher/inventor for more than a decade and his in-depth knowledge of chemistry that has been deepened through 25+ years of industry and academic experience.
Download full bio
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
Global cross-license achieved for Gevo in long-running biofuels patent case
Vitae Pharmaceuticals Completes Initial Public Offering
Cara Therapeutics $55 Million Initial Public Offering
AcelRx Pharmaceuticals in Public Offering
View all
Patent Counseling & Prosecution – Life Sciences
Patent Counseling & Prosecution
Intellectual Property
Patent Office Litigation
Life Sciences
The Catholic University of America, Columbus School of LawJD, ABA – BNA Award for Excellence in the Study of Intellectual Property Law, 2002
University of Wisconsin-MadisonPh.D., Organic Chemistry, 1985
Cornell UniversityBA, Chemistry, 1979
District of Columbia
Registered to practice before the United States Patent & Trademark Office (USPTO)
Virginia
Cardioxyl Sells to Bristol-Myers Squibb for up to $2 Billion November 5, 2015
Gevo and Butamax Successfully Resolve Multi-Year Patent Dispute August 27, 2015
Vitae Pharmaceuticals Completes Initial Public Offering October 10, 2014
American Bar Association
New Jersey Intellectual Property Law Association
Legal 500: Patent Prosecution
US patents from over 13 years of industrial research experience
+1 202 842 7865 office +1 202 842 7899 fax tblinka@cooley.com
1299 Pennsylvania Avenue, NWSuite 700Washington, DC 20004-2400